Edition:
United States

Walvax Biotechnology Co Ltd (300142.SZ)

300142.SZ on Shenzhen Stock Exchange

27.64CNY
19 Apr 2019
Change (% chg)

¥-0.56 (-1.99%)
Prev Close
¥28.20
Open
¥28.30
Day's High
¥28.30
Day's Low
¥27.33
Volume
15,279,296
Avg. Vol
14,125,320
52-wk High
¥29.95
52-wk Low
¥12.90

Latest Key Developments (Source: Significant Developments)

Walvax Biotechnology Swings Back To Black With Preliminary Net Profit In 2018
Thursday, 21 Feb 2019 07:18am EST 

Feb 21 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ>::SAYS PRELIM 2018 NET PROFIT AT 1.0 BILLION YUAN ($148.89 million) VERSUS NET LOSS OF 537.1 MILLION YUAN YEAR EARLIER.  Full Article

Walvax Biotechnology Expects To Swing Back To Black In 2018
Friday, 25 Jan 2019 07:39am EST 

Jan 25 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ>::SAYS IT SEES 2018 NET PROFIT AT BETWEEN 1.04 BILLION YUAN ($153.93 million) AND 1.05 BILLION YUAN VERSUS NET LOSS 537.1 MILLION YUAN.  Full Article

Shenzhen Exchange Filing Shows Block Trade Of Walvax Biotechnology's Shares Involving 108.08 Mln Yuan
Wednesday, 31 Oct 2018 04:27am EDT 

Oct 31 (Reuters) - Shenzhen Stock Exchange ::FILING SHOWS BLOCK TRADE OF WALVAX BIOTECHNOLOGY CO LTD'S <<<300142.SZ>>> 7.0 MILLION SHARES INVOLVING 108.08 MILLION YUAN ($15.50 million) ON OCT 31.  Full Article

Walvax Biotechnology to swing to profit in 2018 H1
Wednesday, 4 Jul 2018 11:03pm EDT 

July 5 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ> ::Sees it swing to net profit at 71.8 million yuan to 76.8 million yuan in 2018 H1 versus net loss at 43 million yuan in 2017 H1 .  Full Article

Walvax Biotechnology expects to return to net profit for 2018 Q1
Tuesday, 10 Apr 2018 07:42am EDT 

April 10(Reuters) - Walvax Biotechnology Co Ltd <300142.SZ> ::Says it expects 2018 Q1 to return to net profit of 19 million yuan to 24 million yuan from net loss of 29.3 million yuan year ago.  Full Article

Walvax Biotechnology's Prelim 2017 Net Loss Of 535.02 Mln Yuan
Monday, 26 Feb 2018 07:49am EST 

Feb 26 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ>::SAYS PRELIM 2017 NET LOSS OF 535.02 MILLION YUAN ($84.83 million) VERSUS NET PROFIT OF 70.46 MILLION YUAN YEAR AGO.  Full Article

Walvax Biotechnology Revises 2017 Results, Sees 2017 Net Loss At 533.5-538.5 Mln Yuan
Friday, 12 Jan 2018 05:36am EST 

Jan 12 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ>::SAYS IT REVISES 2017 RESULTS, SEES 2017 NET LOSS AT 533.5-538.5 MILLION YUAN ($82.63-$83.40 million)VERSUS 70.46 MILLION YUAN NET PROFIT YEAR AGO.  Full Article

Walvax Biotechnology unit gets approval for clinical trail on new drug GB223 injection
Tuesday, 2 Jan 2018 05:23am EST 

Jan 2 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ> ::Says its controlling biotech unit got approval for clinical trail of new drug GB223 injection, which is used for treatment of osteoporosis, bone metastasis of solid tumor and other related diseases .  Full Article

Walvax Biotechnology to sell 100 pct stake in Jiangsu-based biotech unit
Monday, 18 Dec 2017 11:08pm EST 

Dec 19(Reuters) - Walvax Biotechnology Co Ltd <300142.SZ>:Says it plans to sell 100 percent stake in a Jiangsu-based biotechnology unit to a Guangzhou-based biotechnology firm (buyer) for 90 million yuan, and to transfer split influenza virus vaccine related project to buyer at the same time.  Full Article

Limited partnership to invest 650 mln yuan in Walvax Biotechnology's unit
Monday, 4 Dec 2017 04:22am EST 

Dec 4(Reuters) - Walvax Biotechnology Co Ltd <300142.SZ>:Says a Tianjin-based limited partnership plans to invest 650 million yuan in co's biotechnology unit.Says the limited partnership will hold 11.3 percent stake in unit after investment.  Full Article